Review
Improving Treatment for Drug-Exposed Infants
Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 1993. Report No.: (SMA) 93-2011.
- PMID: 22514857
- Bookshelf ID: NBK64750
Item in Clipboard
Review
Improving Treatment for Drug-Exposed Infants
Excerpt
The primary focus of this Treatment Improvement Protocol (TIP) is the in utero exposure of infants to illicit drugs. In utero exposure to cocaine and opiates, especially heroin, is highlighted, and there is a brief discussion of methadone. Although the substantial crisis of in utero exposure to alcohol is discussed, it is not the focal concern of this TIP. In addition, this TIP highlights medical and psychosocial services for drug-exposed infants up to 18 months of age and their families. Concerns regarding older toddlers and children are mentioned, but they are not the TIP's focus.
Sections
- What Is A TIP?
- Consensus Panel
- Chapter 1 - Introduction
- Chapter 2 - Medical Management of The Drug-Exposed Infant
- Chapter 3 - Followup and Aftercare of Drug-Exposed Infants
- Chapter 4 - Psychosocial Services for Drug-Exposed Infants and Their Families
- Chapter 5 - Ethical and Legal Guidelines
- Chapter 6 - Quality Assurance Guidelines
- Appendix A - Resources
- Appendix B - Sample Programs
- Appendix C - Urine toxicology Guidelines
- Appendix D - Description of IDEA
- Appendix E - Family Service Plan
- Appendix F - Medical Glossary
- Appendix G - Cost Factors
- Appendix H - Federal Resource Panel
- Appendix I - Field Reviewers
- References
Publication types
Grants and funding
This publication is part of the Substance Abuse Prevention and Treatment Block Grant technical assistance program. This publication was written under contract number ADM 270-91-0007 from CSAT. Al Getz, MSW; Anna Marsh, PhD; and Sandra Clunies, MS served as the CSAT government project officers. Lynne Bailey, Carolyn Davis, and Claudia Norris served as contractor writers.
LinkOut - more resources
Full Text Sources
